Literature DB >> 9737785

Mutation of the start codon in the FRDA1 gene: linkage analysis of three pedigrees with the ATG to ATT transversion points to a unique common ancestor.

C Zühlke1, F Laccone, M Cossée, A Kohlschütter, M Koenig, E Schwinger.   

Abstract

Friedreich ataxia (FRDA) is a progressive neurodegenerative disorder caused by loss-of-function mutations in the gene encoding frataxin. Most patients with FRDA have trinucleotide repeat expansions in both alleles of the FRDA 1 gene. In patients heterozygous for the expansion the second allele may be inactivated by a point mutation. We identified the ATG-->ATT (M11) mutation of the start codon in three independent families. Individuals with symptoms of FRDA in these families are compound heterozygous for the repeat expansion and the ATG mutation. To look for a common founder of the M11 mutation, a detailed linkage analysis employing six polymorphic chromosome 9 markers was performed. We found complete haplotype identity for two of the three chromosomes with the point mutation. The third case shows partial conformity and may be the result of a single recombination event.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737785     DOI: 10.1007/s004390050791

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  10 in total

Review 1.  Recent advances in the genetics of cerebellar ataxias.

Authors:  Anna Sailer; Henry Houlden
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

Review 2.  Friedreich ataxia: an overview.

Authors:  M B Delatycki; R Williamson; S M Forrest
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

3.  Psychosis Complicating Friedreich Ataxia.

Authors:  Christos Ganos; Daniel Schöttle; Christine Zühlke; Alexander Münchau
Journal:  Mov Disord Clin Pract       Date:  2014-11-28

4.  Triple therapy with darbepoetin alfa, idebenone, and riboflavin in Friedreich's ataxia: an open-label trial.

Authors:  Javier Arpa; Irene Sanz-Gallego; Francisco J Rodríguez-de-Rivera; Francisco J Domínguez-Melcón; Daniel Prefasi; Javier Oliva-Navarro; Mar Moreno-Yangüela; Samuel I Pascual-Pascual
Journal:  Cerebellum       Date:  2013-10       Impact factor: 3.847

Review 5.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

6.  Frataxin gene point mutations in Italian Friedreich ataxia patients.

Authors:  Cinzia Gellera; Barbara Castellotti; Caterina Mariotti; Rossana Mineri; Viviana Seveso; Stefano Didonato; Franco Taroni
Journal:  Neurogenetics       Date:  2007-08-17       Impact factor: 2.660

Review 7.  Autosomal recessive cerebellar ataxias.

Authors:  Francesc Palau; Carmen Espinós
Journal:  Orphanet J Rare Dis       Date:  2006-11-17       Impact factor: 4.123

8.  IGF-1 in Friedreich's Ataxia - proof-of-concept trial.

Authors:  Irene Sanz-Gallego; Ignacio Torres-Aleman; Javier Arpa
Journal:  Cerebellum Ataxias       Date:  2014-07-04

9.  Comparative Proteomics Enables Identification of Nonannotated Cold Shock Proteins in E. coli.

Authors:  Nadia G D'Lima; Alexandra Khitun; Aaron D Rosenbloom; Peijia Yuan; Brandon M Gassaway; Karl W Barber; Jesse Rinehart; Sarah A Slavoff
Journal:  J Proteome Res       Date:  2017-09-19       Impact factor: 4.466

Review 10.  Down the Iron Path: Mitochondrial Iron Homeostasis and Beyond.

Authors:  Jonathan V Dietz; Jennifer L Fox; Oleh Khalimonchuk
Journal:  Cells       Date:  2021-08-25       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.